Evan L. Riddle, Ph.D. - Publications

Affiliations: 
2003 University of Utah, Salt Lake City, UT 
Area:
Pharmacology, Neuroscience Biology

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Riddle EL, Fleckenstein AE, Hanson GR. Role of monoamine transporters in mediating psychostimulant effects Drug Addiction: From Basic Research to Therapy. 169-177. DOI: 10.1007/978-0-387-76678-2_11  0.84
2007 Volz TJ, Farnsworth SJ, King JL, Riddle EL, Hanson GR, Fleckenstein AE. Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles. The Journal of Pharmacology and Experimental Therapeutics. 323: 738-45. PMID 17693585 DOI: 10.1124/Jpet.107.126888  0.84
2007 Riddle EL, Hanson GR, Fleckenstein AE. Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2. European Journal of Pharmacology. 571: 25-8. PMID 17618619 DOI: 10.1016/J.Ejphar.2007.05.044  0.84
2007 Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR. New insights into the mechanism of action of amphetamines. Annual Review of Pharmacology and Toxicology. 47: 681-98. PMID 17209801 DOI: 10.1146/Annurev.Pharmtox.47.120505.105140  0.84
2006 Riddle EL, Fleckenstein AE, Hanson GR. Mechanisms of methamphetamine-induced dopaminergic neurotoxicity. The Aaps Journal. 8: E413-8. PMID 16808044 DOI: 10.1007/Bf02854914  0.84
2006 Riddle EL, Rana BK, Murthy KK, Rao F, Eskin E, O'Connor DT, Insel PA. Polymorphisms and haplotypes of the regulator of G protein signaling-2 gene in normotensives and hypertensives. Hypertension. 47: 415-20. PMID 16432041 DOI: 10.1161/01.Hyp.0000200714.81990.61  0.84
2005 Riddle EL, Fleckenstein AE, Hanson GR. Role of monoamine transporters in mediating psychostimulant effects. The Aaps Journal. 7: E847-51. PMID 16594636 DOI: 10.1208/Aapsj070481  0.84
2005 Riddle EL, Schwartzman RA, Bond M, Insel PA. Multi-tasking RGS proteins in the heart: the next therapeutic target? Circulation Research. 96: 401-11. PMID 15746448 DOI: 10.1161/01.Res.0000158287.49872.4E  0.84
2004 Hanson GR, Sandoval V, Riddle E, Fleckenstein AE. Psychostimulants and vesicle trafficking: a novel mechanism and therapeutic implications. Annals of the New York Academy of Sciences. 1025: 146-50. PMID 15542712 DOI: 10.1196/Annals.1316.019  0.84
2004 Baucum AJ, Rau KS, Riddle EL, Hanson GR, Fleckenstein AE. Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 3436-43. PMID 15056723 DOI: 10.1523/Jneurosci.0387-04.2004  0.84
2003 Ugarte YV, Rau KS, Riddle EL, Hanson GR, Fleckenstein AE. Methamphetamine rapidly decreases mouse vesicular dopamine uptake: role of hyperthermia and dopamine D2 receptors. European Journal of Pharmacology. 472: 165-71. PMID 12871750 DOI: 10.1016/S0014-2999(03)01911-3  0.84
2003 Sandoval V, Riddle EL, Hanson GR, Fleckenstein AE. Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits. The Journal of Pharmacology and Experimental Therapeutics. 304: 1181-7. PMID 12604695 DOI: 10.1124/Jpet.102.045005  0.84
2003 Riddle EL, Rau KS, Topham MK, Hanson GR, Fleckenstein AE. Ceramide-induced alterations in dopamine transporter function. European Journal of Pharmacology. 458: 31-6. PMID 12498904 DOI: 10.1016/S0014-2999(02)02727-9  0.84
2002 Sandoval V, Riddle EL, Hanson GR, Fleckenstein AE. Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 8705-10. PMID 12351745 DOI: 10.1523/Jneurosci.22-19-08705.2002  0.84
2002 Riddle EL, Topham MK, Haycock JW, Hanson GR, Fleckenstein AE. Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine. European Journal of Pharmacology. 449: 71-4. PMID 12163108 DOI: 10.1016/S0014-2999(02)01985-4  0.84
2002 Brown JM, Riddle EL, Sandoval V, Weston RK, Hanson JE, Crosby MJ, Ugarte YV, Gibb JW, Hanson GR, Fleckenstein AE. A single methamphetamine administration rapidly decreases vesicular dopamine uptake. The Journal of Pharmacology and Experimental Therapeutics. 302: 497-501. PMID 12130707 DOI: 10.1124/Jpet.302.2.497  0.84
2002 Hansen JP, Riddle EL, Sandoval V, Brown JM, Gibb JW, Hanson GR, Fleckenstein AE. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity. The Journal of Pharmacology and Experimental Therapeutics. 300: 1093-100. PMID 11861820 DOI: 10.1124/Jpet.300.3.1093  0.84
2002 Riddle EL, Kokoshka JM, Wilkins DG, Hanson GR, Fleckenstein AE. Tolerance to the neurotoxic effects of methamphetamine in young rats. European Journal of Pharmacology. 435: 181-5. PMID 11821024 DOI: 10.1016/S0014-2999(01)01592-8  0.84
2001 Sandoval V, Riddle EL, Ugarte YV, Hanson GR, Fleckenstein AE. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 1413-9. PMID 11160413 DOI: 10.1523/Jneurosci.21-04-01413.2001  0.84
1999 Fleckenstein AE, Haughey HM, Metzger RR, Kokoshka JM, Riddle EL, Hanson JE, Gibb JW, Hanson GR. Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function. European Journal of Pharmacology. 382: 45-9. PMID 10556503 DOI: 10.1016/S0014-2999(99)00588-9  0.84
Show low-probability matches.